CONTACTAbout UsCAREER OPPORTUNITIESADVERTISE WITH USPRIVACY POLICYPRIVACY PREFERENCESTERMS OF USELEGAL NOTICE
© 2025 Pride Publishing Inc.
All Rights reserved
All Rights reserved
By continuing to use our site, you agree to our Private Policy and Terms of Use.
Two new studies in the May 29 issue of The New England Journal of Medicine add to the growing evidence that Fuzeon is effective in treating HIV in patients resistant to other antiretroviral drugs, with new data showing the drug doubles the chances for someone with drug resistance to achieve an undetectable viral load. In one of the studies, researchers studied 1,000 patients from 48 cities in the United States, Canada, Mexico, and Brazil who had at least six months of treatment with other anti-HIV drugs and had developed resistance to one or more of the medications. The study concluded that adding Fuzeon to an existing drug cocktail "provided significant antiretroviral and immunologic benefit " for the study participants. A second study, conducted in the United States, Australia, and Europe, also showed Fuzeon to significantly boost the effectiveness of antiretroviral therapy for those already treated with other anti-HIV medications. In an accompanying editorial, Karen Tashima and Charles Carpenter of Miriam Hospital in Providence, R.I., write that the studies offer "heartening news of the success" of Fuzeon because the two research projects provided nearly identical results. But they add that additional issues still need to be worked out, including the high pricing of the medication--Fuzeon is priced at nearly $20,000 for a one-year regimen--and concerns about adverse side effects of the drug. The European Union on Tuesday gave marketing approval to drugmakers Roche and Trimeris to sell Fuzeon in all 15 member nations. The U.S. Food and Drug Administration approved Fuzeon for sale on March 13. Fuzeon, previously known as T-20, is the world's first HIV fusion inhibitor that works outside immune system cells to prevent HIV from attaching to and infecting the cells. All other available anti-HIV medications work to slow HIV replication inside cells already infected with the virus.
From our Sponsors
Most Popular
31 Period Films of Lesbians and Bi Women in Love That Will Take You Back
December 09 2024 1:00 PM
18 of the most batsh*t things N.C. Republican governor candidate Mark Robinson has said
October 30 2024 11:06 AM
True
After 20 years, and after tonight, Obama will no longer be the Democrats' top star
August 20 2024 12:28 PM
Trump ally Laura Loomer goes after Lindsey Graham: ‘We all know you’re gay’
September 13 2024 2:28 PM
These 15 major companies caved to the far right and stopped DEI programs
January 24 2025 1:11 PM
True
Melania Trump cashed six-figure check to speak to gay Republicans at Mar-a-Lago
August 16 2024 5:57 PM
Latest Stories
Trump Pentagon chief Pete Hegseth enacts harshest anti-trans military policies yet
February 11 2025 9:57 AM
Protecting the rights of LGBTQ+ families in the second Trump presidency
February 11 2025 7:00 AM
Three convicted in murders of gay men in New York City
February 10 2025 7:59 PM
Trump's Education Department investigates schools for trans inclusion in sports
February 10 2025 5:53 PM
GLAAD responds as WWE chooses not to renew lesbian wrestler Sonya Deville’s contract
February 10 2025 3:34 PM
Rally for transgender youth overtakes New York City's Union Square, in photos
February 10 2025 2:35 PM
Anti-LGBTQ+ policies harm the health of not only LGBTQ+ people, but all Americans
February 10 2025 1:58 PM
Love Hurts' Ariana DeBose and Ke Huy Quan on living and loving authentically
February 10 2025 1:16 PM
Ro Khanna says that Democrats need to stand firmly behind the trans community
February 10 2025 12:59 PM
Pete Buttigieg and Dana Nessel, out gay and lesbian politicians, lead in early Senate poll
February 10 2025 12:57 PM